Olaparib Maintenance Treatment Versus Placebo in Patients With PSR Ovarian Cancer Who Are in CR or PR to Platinum-based Chemotherapy and Whose Tumours Carry sBRCAm or HRR-associated Genes Mutations
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Charlie Gourley, Prof.
University of Edinburgh
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
29 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Chiclayo, Peru
- Research Site
Lima, Peru
- Research Site
Quezon City, Philippines
- Research Site
Goyang-si, South Korea
- Research Site
Seongnam-si, South Korea
- Research Site
Seoul, South Korea
- Research Site
Birmingham, United Kingdom
- Research Site
Cambridge, United Kingdom
- Research Site
Coventry, United Kingdom
- Research Site
Edinburgh, United Kingdom
- Research Site
London, United Kingdom
- Research Site
Manchester, United Kingdom
- Research Site
Oxford, United Kingdom
- Research Site
Sutton, United Kingdom
- Research Site
Mobile, Alabama, United States
- Research Site
Phoenix, Arizona, United States
- Research Site
Los Angeles, California, United States
- Research Site
Stanford, California, United States
- Research Site
Augusta, Georgia, United States
- Research Site
Park Ridge, Illinois, United States
- Research Site
Iowa City, Iowa, United States
- Research Site
Louisville, Kentucky, United States
- Research Site
Covington, Louisiana, United States
- Research Site
Scarborough, Maine, United States
- Research Site
Baltimore, Maryland, United States
- Research Site
Albany, New York, United States
- Research Site
Oklahoma City, Oklahoma, United States
- Research Site
Philadelphia, Pennsylvania, United States
- Research Site
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2016
- Primary completion
- 30 Jun 2019
- Completion
- 30 Jun 2019
- Last update posted
- 2 May 2016
- Registered enrollment
- 0
- Registry id
- NCT02392676
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.